The leucine-rich repeat (LRR) proteins LRIM1 and APL1C control the function of the complement-like protein TEP1 in Anopheles mosquitoes. The molecular structure of LRIM1 and APL1C and the basis of their interaction with TEP1 represent a new type of innate immune complex. The LRIM1/APL1C complex specifically binds and solubilizes a cleaved form of TEP1 without an intact thioester bond. The LRIM1 and APL1C LRR domains have a large radius of curvature, glycosylated concave face, and a novel C-terminal capping motif. The LRIM1/APL1C complex is a heterodimer with a single intermolecular disulfide bond. The structure of the LRIM1/APL1C heterodimer reveals an interface between the two LRR domains and an extensive C-terminal coiled-coil domain. We propose that a cleaved form of TEP1 may act as a convertase for activation of other TEP1 molecules and that the LRIM1/APL1C heterodimer regulates formation of this TEP1 convertase.host-pathogen interactions | innate immunity | malaria | thioester C omplement is an innate immune system in vertebrates comprising a number of serum proteins that function to detect and destroy microorganisms. Insects possess a complement-like immune response to bacteria, fungi, and protozoan parasites (1-4). Anopheles gambiae thioester-containing protein 1 (TEP1) is structurally and functionally homologous to complement factor C3 (3, 5-7), including an intramolecular thioester bond that mediates covalent labeling of pathogens. Covalent attachment of TEP1 to bacteria promotes their phagocytosis (3), whereas binding of TEP1 to Plasmodium berghei ookinetes targets them for lysis (1).Complement activation centers upon a conformational change in C3 that is regulated by proteolysis. C3 is cleaved twice; first during intracellular processing, then a second activating cleavage that dissociates a small protein domain known as anaphylatoxin, or C3a. This dissociation triggers a large conformational change in the remaining molecule, known as C3b, exposing the thioester bond (8, 9). The proteolytic activation of C3 is regulated by the formation of a transient complex between a protease and a complement factor, known as a convertase.The alternative pathway involves self-activation of C3. Hydrolysis of the C3 thioester bond induces a conformational change, producing C3ðH 2 OÞ which has a similar conformation to C3b. C3ðH 2 OÞ can recruit the protease Factor B. Cleavage of Factor B by Factor D produces the transient complex C3ðH 2 OÞBb that is a C3 convertase (10). The alternative pathway is inhibited in the fluid phase and the presence of self surfaces by the binding of Factor H, which competes with Factor B for binding to the C345C domain of C3 (11, 12).TEP1 lacks both the anaphylatoxin and C345C domains, and is secreted as a full-length molecule. Constitutive cleavage is observed in the hemolymph within a protease-sensitive region similar to that of C3. Proteolysis of TEP1 in the protease-sensitive region in vitro does not appear to cause a conformational change, and the thioester remains present in the result...